drugset / Trial / NCT00753987
Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis
NaSingle-groupOpen-labelTreatment
Summary
The objective of the study is to determine whether or not inhalation of hypertonic saline will be tolerated by infants with cystic fibrosis and the effect of inhalation on their lung function.
Timeline
- Start
- 2006-03
- Primary completion
- 2006-07
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hypertonic saline | Unknown | 5 ml | Inhaled |
| Subject | Hypertonic saline | Unknown | 7 % | Inhaled |